BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 24978641)

  • 1. Melanoma epigenetics: novel mechanisms, markers, and medicines.
    Lee JJ; Murphy GF; Lian CG
    Lab Invest; 2014 Aug; 94(8):822-38. PubMed ID: 24978641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Targeted epigenetic therapy of cancer. Achievements and perspectives].
    Valdespino-Gómez VM; Valdespino-Castillo VE
    Cir Cir; 2012; 80(5):470-80. PubMed ID: 23351455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deregulated chromatin remodeling in the pathobiology of brain tumors.
    Spyropoulou A; Piperi C; Adamopoulos C; Papavassiliou AG
    Neuromolecular Med; 2013 Mar; 15(1):1-24. PubMed ID: 23114751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetics of human cutaneous melanoma: setting the stage for new therapeutic strategies.
    Sigalotti L; Covre A; Fratta E; Parisi G; Colizzi F; Rizzo A; Danielli R; Nicolay HJ; Coral S; Maio M
    J Transl Med; 2010 Jun; 8():56. PubMed ID: 20540720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploiting the Epigenome to Control Cancer-Promoting Gene-Expression Programs.
    Brien GL; Valerio DG; Armstrong SA
    Cancer Cell; 2016 Apr; 29(4):464-476. PubMed ID: 27070701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic regulation of gene expression as an anticancer drug target.
    Ferguson LR; Tatham AL; Lin Z; Denny WA
    Curr Cancer Drug Targets; 2011 Feb; 11(2):199-212. PubMed ID: 21158714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic Regulation in Melanoma: Facts and Hopes.
    Giunta EF; Arrichiello G; Curvietto M; Pappalardo A; Bosso D; Rosanova M; Diana A; Giordano P; Petrillo A; Federico P; Fabozzi T; Parola S; Riccio V; Mucci B; Vanella V; Festino L; Daniele B; Ascierto PA; Ottaviano M; On Behalf Of Scito Youth
    Cells; 2021 Aug; 10(8):. PubMed ID: 34440824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic therapy of cancer with histone deacetylase inhibitors.
    Lakshmaiah KC; Jacob LA; Aparna S; Lokanatha D; Saldanha SC
    J Cancer Res Ther; 2014; 10(3):469-78. PubMed ID: 25313724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetics in human melanoma.
    Howell PM; Liu S; Ren S; Behlen C; Fodstad O; Riker AI
    Cancer Control; 2009 Jul; 16(3):200-18. PubMed ID: 19556960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of epigenetics in malignant pleural mesothelioma.
    Vandermeers F; Neelature Sriramareddy S; Costa C; Hubaux R; Cosse JP; Willems L
    Lung Cancer; 2013 Sep; 81(3):311-318. PubMed ID: 23790315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic biomarkers in skin cancer.
    Greenberg ES; Chong KK; Huynh KT; Tanaka R; Hoon DS
    Cancer Lett; 2014 Jan; 342(2):170-7. PubMed ID: 22289720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic regulation in human melanoma: past and future.
    Sarkar D; Leung EY; Baguley BC; Finlay GJ; Askarian-Amiri ME
    Epigenetics; 2015; 10(2):103-21. PubMed ID: 25587943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trials with 'epigenetic' drugs: an update.
    Nebbioso A; Carafa V; Benedetti R; Altucci L
    Mol Oncol; 2012 Dec; 6(6):657-82. PubMed ID: 23103179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting epigenetic DNA and histone modifications to treat kidney disease.
    Fontecha-Barriuso M; Martin-Sanchez D; Ruiz-Andres O; Poveda J; Sanchez-Niño MD; Valiño-Rivas L; Ruiz-Ortega M; Ortiz A; Sanz AB
    Nephrol Dial Transplant; 2018 Nov; 33(11):1875-1886. PubMed ID: 29534238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Histone methyltransferases: a new class of therapeutic targets in cancer treatment?].
    Chaib H; Prébet T; Vey N; Collette Y
    Med Sci (Paris); 2011; 27(8-9):725-32. PubMed ID: 21880260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the role of epigenetic alterations and non-coding RNAs in melanoma pathogenesis and therapeutic strategies.
    Rubatto M; Borriello S; Sciamarrelli N; Pala V; Tonella L; Ribero S; Quaglino P
    Melanoma Res; 2023 Dec; 33(6):462-474. PubMed ID: 37788101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Promises to Cure Cancer and Other Genetic Diseases/Disorders: Epi-drugs Through Epigenetics.
    Duan YT; Sangani CB; Liu W; Soni KV; Yao Y
    Curr Top Med Chem; 2019; 19(12):972-994. PubMed ID: 31161992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Network assessment of demethylation treatment in melanoma: Differential transcriptome-methylome and antigen profile signatures.
    Jiang Z; Cinti C; Taranta M; Mattioli E; Schena E; Singh S; Khurana R; Lattanzi G; Tsinoremas NF; Capobianco E
    PLoS One; 2018; 13(11):e0206686. PubMed ID: 30485296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on melanoma epigenetics.
    de Unamuno B; Palanca S; Botella R
    Curr Opin Oncol; 2015 Sep; 27(5):420-6. PubMed ID: 26197354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic Biomarkers in Gallbladder Cancer.
    Tiwari PK
    Trends Cancer; 2020 Jul; 6(7):540-543. PubMed ID: 32291238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.